Pathological outcomes of Hong Kong Chinese patients with low risk prostate cancer eligible for active surveillance undergoing radical prostatectomy: comparison of six different protocols

被引:0
|
作者
Tsang, C. F. [1 ]
Tsu, J. H. [1 ]
Ng, A. T. [1 ]
Wong, E. M. [1 ]
Ho, K. L. [1 ]
Yiu, M. K. [1 ]
机构
[1] Queen Mary Hosp, Div Urol, Dept Surg, Hong Kong, Hong Kong, Peoples R China
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
27
引用
收藏
页码:9 / 9
页数:1
相关论文
共 50 条
  • [1] Pathological outcome for Chinese patients with low-risk prostate cancer eligible for active surveillance and undergoing radical prostatectomy: comparison of six different active surveillance protocols
    Tsang, C. F.
    Tsu, James H. L.
    Lai, Terence C. T.
    Wong, K. W.
    Ho, Brian S. H.
    Ng, Ada T. L.
    Ma, W. K.
    Yiu, M. K.
    HONG KONG MEDICAL JOURNAL, 2017, 23 (06) : 609 - 615
  • [2] PATHOLOGICAL OUTCOMES IN PATIENTS WITH CLINICALLY LOW-RISK PROSTATE CANCER DEEMED ELIGIBLE FOR ACTIVE SURVEILLANCE
    Srivastava, A.
    Grover, S.
    Sooriakumaran, P.
    Leung, R.
    Tewari, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 333 - 333
  • [3] Pathological Outcomes of Men Eligible for Active Surveillance After Undergoing Radical Prostatectomy: Are Results Predictable?
    Behbahani, Turang Ed
    Ellinger, Joerg
    Caratozzolo, Daniel Garcia
    Mueller, Stefan C.
    CLINICAL GENITOURINARY CANCER, 2012, 10 (01) : 32 - 36
  • [4] Pathological features after radical prostatectomy for low risk prostate cancer candidates to active surveillance
    Pinheiro, L.
    Farinha, R.
    Silva, T.
    Muresan, C.
    Coelho, H.
    Rangel, R.
    Passarinho, R.
    Nunes, G.
    Correia, R.
    Monteiro, L.
    Fonseca, J.
    Mendes, R.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 279 - 279
  • [5] Predicting Pathological Features at Radical Prostatectomy in Patients with Prostate Cancer Eligible for Active Surveillance by Multiparametric Magnetic Resonance Imaging
    de Cobelli, Ottavio
    Terracciano, Daniela
    Tagliabue, Elena
    Raimondi, Sara
    Bottero, Danilo
    Cioffi, Antonio
    Jereczek-Fossa, Barbara
    Petralia, Giuseppe
    Cordima, Giovanni
    Almeida, Gilberto Laurino
    Lucarelli, Giuseppe
    Buonerba, Carlo
    Matei, Deliu Victor
    Renne, Giuseppe
    Di Lorenzo, Giuseppe
    Ferro, Matteo
    PLOS ONE, 2015, 10 (10):
  • [6] The pathological upgrading after radical prostatectomy in low-risk prostate cancer patients who are eligible for active surveillance: How safe is it to depend on bioptic pathology?
    Verep, Samed
    Erdem, Selcuk
    Ozluk, Yasemin
    Kilicaslan, Isin
    Sanli, Oner
    Ozcan, Faruk
    PROSTATE, 2019, 79 (13): : 1523 - 1529
  • [7] Pathological outcomes of patients on active surveillance progressing to radical prostatectomy: a snapshot from the prostate cancer registry
    Weerakoon, M.
    Evans, S.
    Millar, J.
    Lawrentschuk, N.
    Frydenberg, M.
    Bolton, D.
    Murphy, D.
    BJU INTERNATIONAL, 2014, 113 : 71 - 72
  • [8] Pathological and biochemical outcomes after radical prostatectomy in men with low-risk prostate cancer meeting the Prostate Cancer International: Active Surveillance criteria
    Mitsuzuka, Koji
    Narita, Shintaro
    Koie, Takuya
    Kaiho, Yasuhiro
    Tsuchiya, Norihiko
    Yoneyama, Takahiro
    Kakoi, Narihiko
    Kawamura, Sadafumi
    Tochigi, Tatsuo
    Habuchi, Tomonori
    Ohyama, Chikara
    Arai, Yoichi
    BJU INTERNATIONAL, 2013, 111 (06) : 914 - 920
  • [9] Pathological outcome of Trinidadian men with low risk prostate cancer eligible for active surveillance
    Gooden, K.
    Persaud, M.
    Goetz, L.
    BJU INTERNATIONAL, 2018, 121 : 5 - 5
  • [10] APICAL INVOLVEMENT IS ASSOCIATED WITH ADVERSE PATHOLOGICAL OUTCOMES IN MEN WITH LOW RISK PROSTATE CANCER ELIGIBLE FOR ACTIVE SURVEILLANCE
    Elshafei, Ahmed
    Fareed, Khaled
    Mousa, Ayman S.
    Lundy, Scott
    DeWitt-Foy, Molly E.
    Thomas, Lewis
    Khalifa, Ahmed
    Chueh, Shih-Chieh
    Fergany, Amr
    Stephenson, Andrew
    Klein, Eric
    JOURNAL OF UROLOGY, 2019, 201 (04): : E957 - E958